• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

OSA linked to Reduced Life Quality in Asthma Patients

February 22, 2013 by admin

Quality of life is significantly decreased in adult patients with asthma who are at high risk for obstructive sleep apnea(OSA), results from a Korean study show.

The researchers also found that asthma patients at high risk for OSA were more likely to be older and have a higher body mass index (BMI) than asthma patients at low risk for OSA.

“Obstructive sleep apnea is associated with reduced quality of life in adult patients with asthma” is published in Annals of Allergy, Asthma & Immunology.

Read Abstract.

Lead author Sae-Hoon Kim (Seoul National University Bundang Hospital, Seongnam) and colleagues suggest that “special consideration is needed for the care and treatment of patients with asthma at high risk for OSA, particularly elderly or centrally obese patients.”

The team studied 217 asthma patients (mean age 58.4 years) randomly selected from a tertiary-care clinic who were assessed for OSA risk using the Berlin questionnaire. They also completed the quality-of-life questionnaire for adult Korean patients with asthma and the asthma control test (ACT).

In total, 89 (41.0%) patients were classified as being at high risk for OSA according to the Berlin questionnaire, with the remaining patients classified as being at low risk for the disorder.

After accounting for age and gender, the researchers found that patients at high risk for OSA had significantly lower QLQAKA scores than low-risk patients (64.4 vs 68.1), particularly in the activity domain.

They also found that the mean age of high-risk patients was significantly higher than that of low-risk patients, at 62.9 versus 55.3 years, as was mean BMI (25.7 vs 23.9 kg/m2), visceral fat area (119.6 vs 94.2 cm2), percent body fat (32.0 vs 26.3%), and the prevalence of hypertension (64.0 vs 18.8%).

In addition, high-risk patients had a significantly longer duration of asthma treatment than low-risk patients (123.9 vs 89.3 days).

However, although high-risk patients were more likely to use an inhaled corticosteroid/long-acting β agonist combination than low-risk patients (86.5% vs 75.0%), there were no significant between-group differences regarding ACT scores or lung function.

Kim and team conclude: “Our data provide clinical evidence that OSA is an important contributing factor for poor quality of life in adult patients with asthma and that central abdominal obesity may be involved in this association.”

SOURCE: News Medical

Filed Under: Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy